Stock NEXTCELL PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company NextCell Pharma AB Nasdaq Stockholm

Equities

SE0009723125

Biotechnology & Medical Research

Business Summary

NextCell Pharma AB, formerly Cellaviva AB, is a Sweden-based biopharmaceutical company. The Company is focusing on research and development of stem cell therapies and is also running a tissue establishment and biobank, classified as healthcare provider. NextCell's business concept is to develop and commercialize mesenchymal stem cell products based on the Company's proprietary selection algorithm, primarily for the treatment of autoimmune diabetes, as well as other types of autoimmune diseases.

Sales per Business

SEK in Million2022Weight2023Weight Delta
Cell Therapies
100.0 %
6 100.0 % 10 100.0 % +80.96%

Sales per region

SEK in Million2022Weight2023Weight Delta
Sweden
100.0 %
6 100.0 % 10 100.0 % +80.96%

Managers

Managers TitleAgeSince
Mathias Svahn CEO
 Chief Executive Officer 48 14-03-18
Edvard Smith FOU
 Founder 73 14-03-18
Patrik Fagerholm DFI
 Director of Finance/CFO 57 21-08-31
Anders Essen-Möller CHM
 Chairman 83 13-12-31
Sofia Sisay CTO
 Chief Tech/Sci/R&D Officer 43 21-12-31
Lindsay Davies CTO
 Chief Tech/Sci/R&D Officer 45 19-12-31
Sofie Falk Jansson PRN
 Corporate Officer/Principal 38 17-12-31

Members of the board

Members of the board TitleAgeSince
Anders Essen-Möller CHM
 Chairman 83 13-12-31
Hans-Peter Torsten Ekre FOU
 Founder 74 14-03-18
Edvard Smith FOU
 Founder 73 14-03-18
Camilla Sandberg BRD
 Director/Board Member 57 16-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 34,379,523 20,679,448 ( 60.15 %) 0 60.15 %

Company contact information

NextCell Pharma AB

Hälsovägen 7

141 57, Huddinge

+46 87 35 55 95

http://www.nextcellpharma.com
address NextCell Pharma AB

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.67% 42.19B
LONZA GROUP AG Stock Lonza Group AG
+44.30% 40.15B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.55% 24.63B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.66% 18.2B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.96% 12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.57% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+16.03% 10.4B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-4.80% 9.94B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. NXTCL Stock
  4. Stock
  5. Company NextCell Pharma AB